Fig. 3.

T_EM1 and T_EM17 cell distribution between r-GPA patients with S. aureus nasal carriage and latent CMV infection. a The circulating percentage of T_EM1 and T_EM17 cells within the CD4⁺T_EM cell population in peripheral blood of S. aureus-non-carrying r-GPA patients (open squares; n = 35) and carrying r-GPA patients (filled squares; n = 27). b The circulating percentage of CD4⁺T_EM cells within the CD4⁺ T cell population in peripheral blood, and c the circulating percentage of T_EM1 and T_EM17 cells within the CD4⁺T_EM cell population in peripheral blood of HC CMV-seronegative (open circles; n = 15), CMV-seropositive (filled circles; n = 21), r-GPA patients CMV-seronegative (open squares; n = 28), and CMV-seropositive (filled squares; n = 33). Horizontal lines represent median percentages. ^* p < 0.05, ^** p < 0.01, and ^*** p < 0.001. CD cluster of differentiation, CMV cytomegalovirus, HC healthy control, ns not significant, r-GPA GPA patient in remission, S. aureus, Staphylococcus aureus, T _EM effector memory T cell